首页> 外国专利> Modified heparin with Low Activity, such that (i) Chains retain at least 90 of sulfate groups, (ii) 2 to 25 units of disaccharide 1.2 to 15 kDa. (iii) has a reduced sequence of saccharides and (iv) a reduction of AC drives. Iduronico glucuronic and / 0 without sulfates; procedure; and their use in malaria

Modified heparin with Low Activity, such that (i) Chains retain at least 90 of sulfate groups, (ii) 2 to 25 units of disaccharide 1.2 to 15 kDa. (iii) has a reduced sequence of saccharides and (iv) a reduction of AC drives. Iduronico glucuronic and / 0 without sulfates; procedure; and their use in malaria

机译：修饰的肝素，具有低活性，因此（i）链保留至少90％的硫酸根，（ii）2至25个单位的二糖1.2至15 kDa。（iii）糖类序列减少，并且（iv）AC驱动器减少。 Iduronico葡萄糖醛酸和// 0，无硫酸盐;程序;及其在疟疾中的用途

页面导航

摘要
著录项
相似文献

摘要

Modified heparin with Low Activity, such that (i) Chains retain at least 90% of sulfate groups, (ii) 2 to 25 units of disaccharide 1.2 to 15 kDa. (iii) reduction has a sequence of saccharides and (iv) a reduction of AC drives. Iduronico glucuronic and / 0 without sulfates; procedure; and their use in malaria

机译：修饰的肝素，具有低活性，因此（i）链保留至少90％的硫酸根，（ii）2至25个单位的二糖1.2至15 kDa。（iii）还原具有一系列糖，并且（iv）还原AC驱动器。 Iduronico葡萄糖醛酸和// 0，无硫酸盐;程序;及其在疟疾中的用途

著录项

公开/公告号CL2014001540A1

专利类型
公开/公告日2014-11-21

原文格式PDF
申请/专利权人 MODUS THERAPEUTICS AB;
展开▼

申请/专利号CL20140001540
发明设计人 EKRE HANS-PETER;LINDAHL ULF;HOLMER ERIK;ERIKSSON PER-OLOV;LEITGEB ANNA;WAHLGREN MATS;TIDIA STEFANIA;LIVERANI LINO;
展开▼

申请日2014-06-11
分类号C08B37/10;A61K31/727;A61P33/06;
国家 CL
入库时间 2022-08-21 15:15:55

相似文献

外文文献